RUVBL1 and neuroblastoma: CSNK2A1 and RUVBL1 have been reported to play multiple roles in driving malignant transformation (Duncan and Litchfield, 2008; Huber et al., 2008), and RUVBL1 expression was identified to be associated with poor overall survival in neuroblastoma patients (Westermann et al., 2008).